Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
Neuropsychiatric Disease and Treatment
|
September 22, 2022
The ESSENCE-Questionnaire for Neurodevelopmental Problems - A Swedish School-Based Validation Study in 11-Year-Old Children
Valdemar Landgren, Leif Svensson, Rajna Knez, et al.
Psychiatry Research
|
June 29, 2025
ASD and ADHD symptoms in 18-year-olds - A population-based study of twins born 1993 to 2001
Olof Arvidsson, Isabell Brikell, Henrik Larsson, et al.
Nutrition and Health
|
June 21, 2018
Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD)
Tobias Banaschewski, Brendan Belsham, Michael H Bloch, et al.
Psychiatry Research
|
August 26, 2025
Corrigendum to "ASD and ADHD symptoms in 18-year-olds - A population-based study of twins born 1993 to 2001"
Olof Arvidsson, Isabell Brikell, Henrik Larsson, et al.
Acta Paediatrica (Oslo, Norway : 1992)
|
June 26, 2025
Bumetanide Treatment in 15 Children With Autism: A Randomised Waitlist-Control Study
Elisabeth Fernell, Sara Landberg, Carmela Miniscalco, et al.
Acta Paediatrica (Oslo, Norway : 1992)
|
October 12, 2023
Neurodevelopmental problems, general health and academic achievements in a school-based cohort of 11-year-old Swedish children
Valdemar Landgren, Leif Svensson, Carl-Johan Törnhage, et al.
CNS Drugs
|
August 21, 2014
Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder
Tobias Banaschewski, Mats Johnson, Michel Lecendreux, et al.
European Child & Adolescent Psychiatry
|
July 4, 2021
A randomized controlled trial of a new intervention in early symptomatic syndromes eliciting neurodevelopmental clinical examinations: PR-ESSENCE
Mats Johnson, Carina Gillberg, Ingrid Vinsa, et al.
Journal of Psychiatric Research
|
August 10, 2021
Long-term medication for ADHD and development of cognitive functions in children and adolescents
Mats Johnson, Jakob Åsberg Johnels, Sven Östlund, et al.
CNS Drugs
|
July 30, 2013
Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder
Tobias Banaschewski, César Soutullo, Michel Lecendreux, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
Neuropsychiatric Disease and Treatment
|
September 22, 2022
The ESSENCE-Questionnaire for Neurodevelopmental Problems - A Swedish School-Based Validation Study in 11-Year-Old Children
Valdemar Landgren, Leif Svensson, Rajna Knez, et al.
Psychiatry Research
|
June 29, 2025
ASD and ADHD symptoms in 18-year-olds - A population-based study of twins born 1993 to 2001
Olof Arvidsson, Isabell Brikell, Henrik Larsson, et al.
Nutrition and Health
|
June 21, 2018
Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD)
Tobias Banaschewski, Brendan Belsham, Michael H Bloch, et al.
Psychiatry Research
|
August 26, 2025
Corrigendum to "ASD and ADHD symptoms in 18-year-olds - A population-based study of twins born 1993 to 2001"
Olof Arvidsson, Isabell Brikell, Henrik Larsson, et al.
Acta Paediatrica (Oslo, Norway : 1992)
|
June 26, 2025
Bumetanide Treatment in 15 Children With Autism: A Randomised Waitlist-Control Study
Elisabeth Fernell, Sara Landberg, Carmela Miniscalco, et al.
Acta Paediatrica (Oslo, Norway : 1992)
|
October 12, 2023
Neurodevelopmental problems, general health and academic achievements in a school-based cohort of 11-year-old Swedish children
Valdemar Landgren, Leif Svensson, Carl-Johan Törnhage, et al.
CNS Drugs
|
August 21, 2014
Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder
Tobias Banaschewski, Mats Johnson, Michel Lecendreux, et al.
European Child & Adolescent Psychiatry
|
July 4, 2021
A randomized controlled trial of a new intervention in early symptomatic syndromes eliciting neurodevelopmental clinical examinations: PR-ESSENCE
Mats Johnson, Carina Gillberg, Ingrid Vinsa, et al.
Journal of Psychiatric Research
|
August 10, 2021
Long-term medication for ADHD and development of cognitive functions in children and adolescents
Mats Johnson, Jakob Åsberg Johnels, Sven Östlund, et al.
CNS Drugs
|
July 30, 2013
Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder
Tobias Banaschewski, César Soutullo, Michel Lecendreux, et al.
Page
of 6